OR WAIT null SECS
Advancements in personalized medicine and other innovations are transforming the way dosage forms are viewed.
This study aimed to develop a taste-masked drug resin complex using the ion exchange resin Kyron T-114.
Novel genetic engineering technologies are transforming the design and manufacture of bispecific antibodies, which are emerging as a promising new class of biologics.
June 12, 2014
A new report from GlobalData states that biosimilars will overtake the market share after 2019.
May 27, 2014
GSK reports 5-year vaccine price freeze for countries graduating from GAVI Alliance.
May 21, 2014
Progress in equipment availability, process analytical technology, and advanced process control aids ongoing development of continuous solid-dosage manufacturing processes.
May 15, 2014
New manufacturing capacity at the Le Mans, France facility is being used to scale up antibody drug conjugates.
What challenges do biopharmaceutical manufacturers face when deciding to move from a fed batch process to a continuous process?
A global contract manufacturer of biologics discusses the increasing impact of health-based exposure limits in assessing cross-contamination risks.
What is a modular system and how are modular systems being used in the biopharmaceutical industry? Pär
Application of single-use technology in a parenteral facility for syringe filling.
May 14, 2014
An interview with Doug Hausner, C-SOPS, about continuous manufacturing
Draft guidance addresses the use of clinical pharmacology studies to determine biosimilarity of biologics.